December wholesales are low, retails are high. January sales numbers show a growth of almost 14%. However, the beginning of January had low inventory in the network. The industry’s stock level has increased. Price hikes are limited, but commodity movements need to be monitored.
Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil
Biocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis received full allocation under the